Covington-Led Bristol Myers To Buy Karuna In $14B Deal
By Al Barbarino · December 22, 2023, 9:12 AM EST
Covington & Burling LLP-advised Bristol Myers Squibb said Friday it has agreed to buy Boston-based biotechnology company Karuna Therapeutics Inc. for $14 billion, leading Karuna's stock to jump more than 47%...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login